Work

A phase I study of prolonged infusion of triapine in combination with a fixed-dose rate of gemcitabine in patients with advanced solid tumors.

Year: 2010

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2010.28.15_suppl.2602

Authors: A. Mortazavi, D. Deam, Y. Ling, E. J. Harper, M. A. Phelps, I. J. Espinoza-Delgado, J. P. Monk, G. A. Otterson, M. R. Grever, T. Bekaii-Saab

Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Wexner Medical Center, The Ohio State University, City Of Hope National Medical Center, National Cancer Institute

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, National Institutes of Health, National Cancer Institute

OpenAlex ID: W2589286309

Cites: 37

Cited by: 1

Related to: 10